Revenue Breakdown
Composition ()
No data
Revenue Streams
InspireMD Inc (NSPR) generates its revenue primarily from CGuard, which accounts for 100.0% of total sales, equivalent to $1.76M. Understanding this concentration is critical for investors evaluating how NSPR navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, InspireMD Inc maintains a gross margin of 34.24%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -517.28%, while the net margin is -503.69%. These profitability ratios, combined with a Return on Equity (ROE) of -87.61%, provide a clear picture of how effectively NSPR converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, NSPR competes directly with industry leaders such as STSS and BEAT. With a market capitalization of $70.64M, it holds a leading position in the sector. When comparing efficiency, NSPR's gross margin of 34.24% stands against STSS's 45.25% and BEAT's N/A. Such benchmarking helps identify whether InspireMD Inc is trading at a premium or discount relative to its financial performance.
